Virological characteristics of the SARS-CoV-2 JN.1 variant.

Kaku, Yu; Okumura, Kaho; Padilla-Blanco, Miguel; Kosugi, Yusuke; Uriu, Keiya; Hinay, Alfredo A; Chen, Luo; Plianchaisuk, Arnon; Kobiyama, Kouji; Ishii, Ken J; Zahradnik, Jiri; Ito, Jumpei; Sato, Kei

Kaku, Yu; Okumura, Kaho; Padilla-Blanco, Miguel; Kosugi, Yusuke; Uriu, Keiya; Hinay, Alfredo A; Chen, Luo; Plianchaisuk, Arnon; Kobiyama, Kouji; Ishii, Ken J; Zahradnik, Jiri; Ito, Jumpei; Sato, Kei.

Affiliation

Kaku Y; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Okumura K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Faculty of Liberal Arts, Sophia University, Tokyo, Japan.
Padilla-Blanco M; First Medical Faculty at Biocev, Charles University, Prague, Czechia; Departamento de Farmacia, Facultad de Ciencias de la Salud, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.
Kosugi Y; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Uriu K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Hinay AA; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Chen L; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.
Plianchaisuk A; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Kobiyama K; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Ishii KJ; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Zahradnik J; First Medical Faculty at Biocev, Charles University, Prague, Czechia.
Ito J; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan.
Sato K; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; Graduate School of Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo 113-8654, Japan; International Vaccine Design Cente

Lancet Infect Dis ; 24(2): e82, 2024 Feb.

Article de En | MEDLINE | ID: mdl-38184005

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Limites: Humans Langue: En Journal: Lancet Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2024 Type de document: Article Pays d'affiliation: Japon

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google